BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:177Lu-DFC413 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of 177Lu-DFC413\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07261631-2294@assetmemo.bio
DTSTAMP:20261121T005424Z
DTSTART;VALUE=DATE:20290509
DTEND;VALUE=DATE:20290510
SUMMARY:177Lu-DFC413: Phase 1 readout est. (NCT07261631)
DESCRIPTION:177Lu-DFC413\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: Ph
 ase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors\nEstimated p
 rimary completion: 9 May 2029. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/177lu-dfc413#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT07261631
URL:https://assetmemo.bio/drug/177lu-dfc413#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
